| Pharmaceutical active ingredients: |
| Estrogens ConjugatedMedrogestone |
| Available forms, composition and doses of Prempak: |
| Tablets; Oral; Estrogens Conjugated; Medrogestone |
| Prempak medical category: |
| Human |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| G03CA57 - Conjugated EstrogensG03FB07 - Medrogestone and estrogen |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Wyeth |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Premia Continuous | Estrogens Conjugated; Medroxyprogesterone Acetate | Wyeth |
| Premia Low | Estrogens Conjugated; Medroxyprogesterone Acetate | Wyeth |
| Premique | Estrogens Conjugated; Medroxyprogesterone Acetate | Wyeth |
| Premique Cycle | Estrogens Conjugated; Medroxyprogesterone Acetate | Wyeth |
| Premique Low Dose | Estrogens Conjugated; Medroxyprogesterone Acetate | Wyeth |
| Prempak N | Estrogens Conjugated; Medrogestone | Wyeth |
| Prempak-C | Estrogens Conjugated; Norgestrel | Wyeth |
| Premphase | Estrogens Conjugated; Medroxyprogesterone Acetate | Wyeth |
| Premphase 14 / 14 | Estrogens Conjugated; Medroxyprogesterone Acetate | Wyeth |
| Prempro | Estrogens Conjugated; Medroxyprogesterone Acetate | Wyeth |